According to a new market research report published by sheer analytics and insights, “The Global External Ventricular Drain Market was valued at $5.1 Billion in 2020. Growing at a high CAGR of more than 7.3% between 2021 and 2031, it is estimated to reach $11.3 Billion by 2031”, as per the latest market research report titled, Global External Ventricular Drain Market - industry analysis, size, share, growth, trends and forecast, 2031 – 2031.
Increased incidences of neurological disorders and the increased road accidents resulting in traumatic brain injuries are the main factors that will help to accelerate the growth of this market during the forecasted period. Also, the increased research activities and the increased adoption of technologically advanced products also help the market to grow during the forecasted period.
Geographically, The Global External Ventricular Drain Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.
The primary key players in Global External Ventricular Drain Market include Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Dispomedica GmbH, Integra LifeSciences, Möller Medical GmbH, B. Braun Melsungen AG, Fuji Systems, Zebra Medical, Neuromedex GmbH, Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Healthy Life Pharma., Geistlich Pharma Inc.
The Global External Ventricular Drain Market Has Been Segmented Into:
Global External Ventricular Drain Market, By Product Type
Global External Ventricular Drain Market, By Application Type
Global External Ventricular Drain Market, By End-Use Type
Global External Ventricular Drain Market, By Region